Armata Pharmaceuticals, Inc. (ARMP)

[Theo]

The one thing I did like (and was hoping to hear more about but didn't) was during the Q & A when one of the analysts asked a multi-question. I don't remember who handled the answer (pretty sure it was PR and not Salka who answered. Anyway, it was the way he said (I'm paraphrasing cause I can't remember the exact wording) "...outside interest from potential business partners had picked up considerably recently". THAT is what I was hoping for and was hoping to hear more of. Phase II is going to take most of 2017 so unless they have something that shows dramatic results mid study, it appears that it will be a slow year ahead of us until results are available. Admittedly, they have other stuff in the pipeline that I don't follow so there certainly could be other things that pop up before then...